A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease
Maher-Edwards, Gareth, De'Ath, Jeni, Barnett, Carly, Lavrov, Arseniy, Lockhart, Andrew
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2015)
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2015)
Get full text
Journal Article
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
Maher-Edwards, Gareth, Dixon, Ruth, Hunter, Jackie, Gold, Michael, Hopton, Gillian, Jacobs, Gemma, Hunter, Jo, Williams, Pauline
Published in International journal of geriatric psychiatry (01.05.2011)
Published in International journal of geriatric psychiatry (01.05.2011)
Get full text
Journal Article
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
Keutzer, Lina, You, Huifang, Farnoud, Ali, Nyberg, Joakim, Wicha, Sebastian G, Maher-Edwards, Gareth, Vlasakakis, Georgios, Moghaddam, Gita Khalili, Svensson, Elin M, Menden, Michael P, Simonsson, Ulrika S. H
Published in Pharmaceutics (22.07.2022)
Published in Pharmaceutics (22.07.2022)
Get full text
Journal Article
Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
Maher-Edwards, Gareth, Watson, Carolyn, Ascher, John, Barnett, Carly, Boswell, Diane, Davies, John, Fernandez, Manuel, Kurz, Alexander, Zanetti, Orazio, Safirstein, Beth, Schronen, Juan Paul, Zvartau-Hind, Marina, Gold, Michael
Published in Alzheimer's & dementia : translational research & clinical interventions (01.06.2015)
Published in Alzheimer's & dementia : translational research & clinical interventions (01.06.2015)
Get full text
Journal Article
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
Diacon, Andreas H, Barry, 3rd, Clifton E, Carlton, Alex, Chen, Ray Y, Davies, Matt, de Jager, Veronique, Fletcher, Kim, Koh, Gavin C K W, Kontsevaya, Irina, Heyckendorf, Jan, Lange, Christoph, Reimann, Maja, Penman, Sophie L, Scott, Rhona, Maher-Edwards, Gareth, Tiberi, Simon, Vlasakakis, Georgios, Upton, Caryn M, Aguirre, David Barros
Published in Nature medicine (01.03.2024)
Published in Nature medicine (01.03.2024)
Get full text
Journal Article
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment
Nuermberger, Eric L, Martínez-Martínez, Maria Santos, Sanz, Olalla, Urones, Beatriz, Esquivias, Jorge, Soni, Heena, Tasneen, Rokeya, Tyagi, Sandeep, Li, Si-Yang, Converse, Paul J, Boshoff, Helena I, Robertson, Gregory T, Besra, Gurdyal S, Abrahams, Katherine A, Upton, Anna M, Mdluli, Khisimuzi, Boyle, Gary W, Turner, Sam, Fotouhi, Nader, Cammack, Nicholas C, Siles, Juan Miguel, Alonso, Marta, Escribano, Jaime, Lelievre, Joel, Rullas-Trincado, Joaquin, Pérez-Herrán, Esther, Bates, Robert H, Maher-Edwards, Gareth, Barros, David, Ballell, Lluís, Jiménez, Elena
Published in Antimicrobial agents and chemotherapy (21.06.2022)
Published in Antimicrobial agents and chemotherapy (21.06.2022)
Get full text
Journal Article
The Africa non-communicable diseases (NCD) Open Lab: Impact of a portfolio of clinical studies to deepen the understanding of NCDs in sub-Saharan Africa
Addo, Juliet, Davy, Maria, Newlands, Amy, Orford, Lindsay, Guta, Phyllis, Scott, Rhona, van Hasselt, James, Maher-Edwards, Gareth
Published in Journal of global health (03.05.2024)
Published in Journal of global health (03.05.2024)
Get full text
Journal Article
Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease
Maher-Edwards, G, Zvartau-Hind, M, Hunter, A J, Gold, M, Hopton, G, Jacobs, G, Davy, M, Williams, P
Published in Current Alzheimer research (01.08.2010)
Published in Current Alzheimer research (01.08.2010)
Get more information
Journal Article
Effect of 6 months of monotherapy with the 5HT6 receptor antagonist SB-742457 or donepezil in subjects with mild-to-moderate Alzheimer's disease
Maher-Edwards, Gareth, Davies, John, Alexander, Kurz, Schronen, Juan, Boswell, Diane, Ascher, John, Gold, Michael
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
O2‐05‐02: Effect of 6 months of monotherapy with the 5HT6 receptor antagonist SB‐742457 or donepezil in subjects with mild‐to‐moderate Alzheimer's disease
Maher‐Edwards, Gareth, Davies, John, Alexander, Kurz, Schronen, Juan, Boswell, Diane, Ascher, John, Gold, Michael
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study: SB-742457 in mild-to-moderate Alzheimer's disease
Maher-Edwards, Gareth, Dixon, Ruth, Hunter, Jackie, Gold, Michael, Hopton, Gillian, Jacobs, Gemma, Hunter, Jo, Williams, Pauline
Published in International journal of geriatric psychiatry (01.05.2011)
Published in International journal of geriatric psychiatry (01.05.2011)
Get full text
Journal Article
Effects of 6-month monotherapy treatment with the 5HT6 receptor antagonist SB 742457 or donepezil in subjects with mild-to-moderate Alzheimer's disease
Maher-Edwards, Gareth, Zvartau-Hind, Marina, Davies, John, Alexander, Kurz, Schronen, Juan, Boswell, Diane, Ascher, John, Gold, Michael
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
P4‐213: Effects of 6‐month monotherapy treatment with the 5HT6 receptor antagonist SB 742457 or donepezil in subjects with mild‐to‐moderate Alzheimer's disease
Maher‐Edwards, Gareth, Zvartau‐Hind, Marina, Davies, John, Alexander, Kurz, Schronen, Juan, Boswell, Diane, Ascher, John, Gold, Michael
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
48-week efficacy and tolerability of treatment with SB-742457, a novel 5HT6 receptor antagonist, when added on to donepezil in subjects with mild-to-moderate Alzheimer's disease (AD)
Maher-Edwards, Gareth, Ascher, John, Watson, Carolyn, Zvartau-Hind, Marina, Donovan, Carly, Davies, John, Safirstein, Beth, Zanetti, Orazio, Fernandez, Manuel, Gold, Michael
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
O4‐06‐06: 48‐week efficacy and tolerability of treatment with SB‐742457, a novel 5HT6 receptor antagonist, when added on to donepezil in subjects with mild‐to‐moderate Alzheimer's disease (AD)
Maher‐Edwards, Gareth, Ascher, John, Watson, Carolyn, Zvartau‐Hind, Marina, Donovan, Carly, Davies, John, Safirstein, Beth, Zanetti, Orazio, Fernandez, Manuel, Gold, Michael
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
Predictors of Placebo Group Decline in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in 24 Week Clinical Trials of Alzheimer's Disease
Irizarry, Michael C., Webb, David J., Bains, Chanchal, Barrett, Steven J., Lai, Robert Y., Laroche, Janette P., Hosford, David, Maher-Edwards, Gareth, Weil, John G.
Published in Journal of Alzheimer's disease (01.07.2008)
Published in Journal of Alzheimer's disease (01.07.2008)
Get full text
Journal Article
O3-04-06: Efficacy and tolerability of SB-742457, a novel 5HT 6 receptor antagonist, in subjects with mild-to-moderate Alzheimer's disease (AD)
Zvartau-Hind, Marina, Maher-Edwards, Gareth, Hunter, Jackie, Gold, Michael, Hopton, Gillian, Davy, Maria, Williams, Pauline
Published in Alzheimer's & dementia (01.07.2008)
Published in Alzheimer's & dementia (01.07.2008)
Get full text
Journal Article